Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-small Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03824977
What this trial is testing

Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery

Who this might be right for
Lung Neoplasm MalignantResectable Lung Non-Small Cell Carcinoma
University Hospital, Rouen 122
Testing effectiveness (Phase 2)Looking for participantsNCT06667167
What this trial is testing

First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy

Who this might be right for
NSCLC (non-small Cell Lung Cancer)
Nir Peled 21
Early research (Phase 1)Study completedNCT02812667
What this trial is testing

Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Lyudmila Bazhenova, M.D. 18
Testing effectiveness (Phase 2)Ended earlyNCT00519831
What this trial is testing

Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC

Who this might be right for
Lung Cancer
UNC Lineberger Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Ended earlyNCT00351039
What this trial is testing

Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 8
Early research (Phase 1)Study completedNCT01225302
What this trial is testing

Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
AbbVie 12
Early research (Phase 1)UnknownNCT01242072
What this trial is testing

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies

Who this might be right for
MalignancyCancerNon Small Cell Lung Cancer+5 more
Alaunos Therapeutics 12
Early research (Phase 1)Study completedNCT00967577
What this trial is testing

177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors

Who this might be right for
Kidney CancerHead and Neck CancerBreast Cancer+6 more
Weill Medical College of Cornell University 20
Not applicableActive Not RecruitingNCT05537701
What this trial is testing

Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study)

Who this might be right for
Non-small Cell Lung Cancer
Centre Hospitalier Universitaire de Liege 316
Testing effectiveness (Phase 2)UnknownNCT01707329
What this trial is testing

Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment

Who this might be right for
Non-small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT00831545
What this trial is testing

Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)

Who this might be right for
Metastases of Central Nervous SystemMelanomaBreast Neoplasm+1 more
Merck Sharp & Dohme LLC 162
Early research (Phase 1)Ended earlyNCT06560645
What this trial is testing

PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Carcinoma+7 more
Prelude Therapeutics Incorporated 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT05020457
What this trial is testing

SI-B001 Combined With Chemotherapy in the Treatment of EGFR/ALK WT Recurrent or Metastatic NSCLC.

Who this might be right for
Non Small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 69
Testing effectiveness (Phase 2)Ended earlyNCT03361228
What this trial is testing

Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors

Who this might be right for
Solid Tumors
Incyte Corporation 5
Testing effectiveness (Phase 2)UnknownNCT01305967
What this trial is testing

Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
SBPharmaceutical IND, Co., LTD 20
Testing effectiveness (Phase 2)Study completedNCT01076231
What this trial is testing

Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine 34
Large-scale testing (Phase 3)Study completedNCT03515837
What this trial is testing

Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 492
Not applicableStudy completedNCT02977845
What this trial is testing

Effect of Qigong on the Symptom Clusters of Dyspnea, Fatigue, and Anxiety.

Who this might be right for
Lung Cancer, Nonsmall CellLung Cancer Non-Small Cell Stage 0Lung Cancer, Nonsmall Cell, Stage I+2 more
Nam Dinh University of Nursing 162
Testing effectiveness (Phase 2)Study completedNCT01588145
What this trial is testing

Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
Hanmi Pharmaceutical Company Limited 273
Testing effectiveness (Phase 2)Looking for participantsNCT07103395
What this trial is testing

A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer (NSCLC)
Sun Yat-sen University 56
Next Page